AI M&A in 2026: Major Deals and Companies Driving Industry Growth

Explore major AI M&A deals and the companies driving industry growth in 2026 as businesses invest in technology, infrastructure, talent, and AI capabilities.

NORTH RICHLAND HILLS, TX, UNITED STATES, September 14, 2026 /EINPresswire.com/ -- AI M&A in 2026 has emerged as one of the most active corners of the global deal market, even as overall corporate dealmaking has become more selective. Buyers across industries are running fewer processes and applying deeper scrutiny before committing capital, yet acquisitions tied to artificial intelligence have continued at a pace and at valuations that outstrip most other categories of deal activity. Covenant Health Advisors is tracking these developments closely as part of its ongoing work advising healthcare organizations and other clients navigating a rapidly consolidating industry.

Global M&A value reached approximately $1.6 trillion in the first half of 2026, an increase of roughly 28% over the same period in 2025, according to research published by Boston Consulting Group. Megadeal activity, transactions valued at $10 billion or more, nearly doubled year over year, reaching 31 deals in the first six months of 2026 compared with 17 in the first half of 2025. Despite these headline figures, broader sentiment indicators remain below long-term historical averages, reflecting a market in which capital is concentrated in a narrower set of sectors and transaction types than in previous cycles.

Major AI M&A Deals in 2026

Several transactions illustrate where capital has concentrated so far this year. Reported activity has included a large-scale utility acquisition tied to AI infrastructure and data-center power demand, as well as direct acquisitions of AI companies focused on cloud infrastructure for AI agents and on data-center cooling technology. Large financing arrangements have also been used to expand AI infrastructure capacity outside of traditional acquisition structures.

Together, these examples point to a market in which infrastructure-layer assets, including computing capacity and power generation, are commanding premium valuations tied to visible, contracted demand, while application-layer AI companies are seeing valuations correct downward as buyers apply more rigorous diligence standards.

AI Industry Consolidation Across Sectors

AI industry consolidation is not confined to the technology sector. Financial services has recorded some of the strongest deal sentiment of any industry, as banks and insurers pursue acquisitions to obtain AI capability and technology infrastructure they cannot build internally on a comparable timeline. Energy and utilities have undergone a similar shift, as power availability has become a binding constraint on AI-driven growth and has reshaped acquisition priorities across the sector.

Healthcare has also shifted toward more constructive deal sentiment, with large pharmaceutical companies pursuing bolt-on acquisitions of biotechnology firms with validated platforms ahead of coming patent expirations, and with medical technology and AI-enabled diagnostics forming a second pillar of activity as care delivery continues to move outside traditional hospital settings.

How AI Is Changing M&A

How AI is changing M&A extends beyond deal volume and valuation. Strategic acquirers report that the criteria used to evaluate AI targets have tightened considerably. Buyers are placing less weight on general-purpose AI models, which are increasingly viewed as commoditized, and more weight on proprietary data, workflows, and production-level deployment that make an AI product defensible over time.

Evidence of AI agents generating measurable revenue for paying customers, rather than demonstrations alone, has become a central factor in underwriting decisions. Private equity firms have pursued a related but distinct approach, building platforms that combine multiple vertical AI companies to achieve shared infrastructure and cross-selling opportunities that would be difficult for any single company to reach independently.

Covenant Health Advisors' Role in a Consolidating Market

As strategic acquisitions in artificial intelligence continue to reshape the competitive landscape, Covenant Health Advisors provides buyer-side M&A advisory and sell-side M&A services for healthcare providers navigating this environment.

The firm's advisory work helps healthcare organizations evaluate acquisition opportunities, assess the durability of AI-enabled platforms, and position their businesses for sale or partnership in a market where technology-enabled care delivery and AI-enabled diagnostics are increasingly central to buyer strategy.

As a healthcare M&A consulting company, Covenant Health Advisors works with providers, investors, and healthcare technology companies to evaluate opportunities arising from AI business acquisitions and broader industry consolidation trends.

Outlook

Market observers point to a coming wave of large technology public listings as a potential catalyst that could reset risk appetite across the broader deal market in the second half of 2026. Until that plays out, the pattern likely to persist is one in which infrastructure and power-related assets continue to command premium valuations on the strength of AI-driven demand, application-layer AI companies face continued valuation discipline, and buyers with clearly defined acquisition theses and rigorous diligence processes are positioned to capture the greatest advantage.

About Covenant Health Advisors

Covenant Health Advisors is a healthcare-focused M&A advisory firm that provides buyer-side and sell-side transaction advisory services to healthcare providers, investors, and healthcare technology companies. The firm supports clients through the evaluation, structuring, and execution of acquisitions, divestitures, and strategic partnerships within the healthcare sector, including transactions involving AI-enabled healthcare technology and diagnostics.

Media Contact:
Contact Name: Chris Calcagno
Company: Covenant Health Advisors
Phone: 214-234-8812
Email: chris.calcagno@covenanthealthadvisors.com

Address: 8225 Westwind Lane, North Richland Hills, TX 76182-8497, United States

Chris Calcagno
Covenant Health Advisors
+1 214-234-8812
chris.calcagno@covenanthealthadvisors.com
Visit us on social media:
LinkedIn
Facebook
Other